PROVIDER PROFILE · NPI 1578798393

Gopichand PendurtiM.D

Hematology-OncologySaint Joseph, MOI
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,071
Unique beneficiaries
—
Total services
24,050
Distinct HCPCS
37
Medicare payment
$173K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 155 Hematology-Oncology providers in MO — top quintile (cohort median 981).
PRESCRIBING · PART D · 2024
Total Rx claims
399
Beneficiaries
—
Total drug cost
$51K
Distinct drugs
18
Brand share
34.3%
Top prescribed drugs
Apixaban36 claims
Levofloxacin33 claims
Prednisone32 claims
Acyclovir32 claims
QUALITY · MIPS · 2024
Final MIPS score
82.7
Quality
62.0
Cost
84.4
Improvement activities
40.0
Promoting interop.
90.0
Payment adjustment
0.32%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$3K
Payment records
102
By payment type
Food and Beverage$2K
Education$145
Top paying entities
Food and Beverage$2K
Education$145
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (3)

Hospital
Hospital
Hospital
REFERRAL NETWORK

Where Gopichand Pendurti's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Tarek Elrafei
Hematology-Oncology · Bronx, NY
1128
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.